Overview

Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study will assess gastric emptying in patients with symptoms of diabetic gastroparesis treated with tegaserod over 2 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Tegaserod